/OPK

OPKO Health Inc

OPK

$1.57USD↑+5.37%+0.08 today

MARKET CAP

1.2B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$1 – $2

52W RANGE

$1

$2

AI Summary

Stalk

Buy NowMedium

OPK is in a Stage 2 advancing uptrend with a primary Bearish Exhaustion pattern signaling seller fatigue and a likely bottoming bounce. Price is currently pulling back into rising 9- and 20-day EMAs on neutral RSI and moderate volume, offering a high-selectivity speculative entry. With no mean-reversion override, the medium-term bias remains bullish, and buying now into this pullback aligns with the speculative strategy’s emphasis on clear structural support.

↑Ended Q2 with $300M+ cash cushioning operations and R&D
↑Raised full-year revenue outlook to $560–585M, up from prior
↓Diagnostics revenue fell to $74.5M in Q2 from $101.1M prior year

Full analysis →

Buying

5

institutions

Selling

5

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	36.98 M	55.47 M	+746.67 K	+34.3%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	1.59 M	2.38 M	+-649.33 K	-6.7%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	1.24 M	1.86 M	+475.81 K	+113.6%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	412.63 K	472.46 K	+206.31 K	+82.5%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	168.31 K	254.14 K	+-340.18 K	-54.6%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	BUY	145.23 K	217.85 K	+51.90 K	+104.7%	0.00%
MM Millennium Management LLC Q2 2026	BUYNEW	72.30 K	108.45 K	+72.30 K	+0.0%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	400.00	600.00	+-653.00	-50.0%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	0.00	0.00	+-109.54 K	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-45.92 K	-100.0%	0.00%